astar
Wip1 Phosphatase Target May Help Nip Cancer In The Bud
A*STAR scientists have discovered that the enzyme Wip1 phosphatase may be a potential target to halt the progression of cancer.
A*STAR, AstraZeneca To Develop Gram-Negative Antibacterials
A*STAR has signed an agreement with biopharmaceutical company AstraZeneca to develop new drugs to treat gram-negative bacterial infections.
Tackling The Urbanisation Crunch
Associate Professor Lau Hoong Chuin of SMU is tackling a key challenge of urbanisation: how to manage the increasing flow of people and physical goods into cities sustainably.
Translational Inefficiencies In R&D: The Blind Men And The Elephant
Prof. Lawrence Ho of NUHS narrates the classic tale of the blind men and the elephant to explain the translational inefficiencies observed in Singapore’s biomedical research.
Scientists Discover Gene Linked To Fatal Drug Allergy
Researchers have discovered that a gene allele known as HLA-B*13:01 could cause a severe drug reaction to dapsone, commonly prescribed for the treatment of leprosy.
A*STAR, NUS Launch S$148m Center For Nutrition Research
NUS and A*STAR have launched the S$148 million Singapore Center for Nutritional Sciences, Metabolic Diseases, and Human Development.
‘Jekyll-And-Hyde’ Protein May Be Weapon Against Cancer
Researchers have discovered how a 'Jekyll-and-Hyde' protein determines the life and death of cancer cells.
Singapore-Korea Collaboration In Sustainable Chemicals
Research institutes in Singapore and Korea will team up to promote joint research and collaboration in the field of sustainable chemicals.
New View Of Dengue Fever
Researchers have produced a “humanized mouse” to study how the mosquito-borne dengue virus depletes blood platelets.
